Showing results (261-270 of 672) with videos related to

Sort By:
Pageof 68
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|May 22, 2021
Does iron overload in metabolic syndrome affect macrophage profile? A case control studyClément Lahaye, Cécile Gladine, Bruno Pereira, et al.
Annals of Clinical Biochemistry|June 30, 2017
Decreased serum glicentin concentration in patients with severe and morbid obesityJuliette Raffort, Patricia Panaïa-Ferrari, Fabien Lareyre, et al.
Nutrients|July 9, 2022
Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose DysmetabolismJustine Gillard, Corinne Picalausa, Christoph Ullmer, et al.
Clinical Science (London, England : 1979)|August 24, 2002
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cellsAbdelmejid Kandoussi, François Martin, Marc Hazzan, et al.
Blood|October 24, 2002
Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formationRobert Kleemann, Philippe P Gervois, Lars Verschuren, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Efficient gene regulation by PPAR gamma and thiazolidinediones in skeletal muscle and heartRaphaël Darteil, Manping Wang, Martine Latta-Mahieu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 10, 2010
Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in miceJohanna H M Stroeve, Gemma Brufau, Frans Stellaard, et al.
The Journal of Biological Chemistry|June 18, 2003
Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzymeOlivier Barbier, Daniel Duran-Sandoval, Inés Pineda-Torra, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 5, 2005
PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemiaNathalie Hennuyer, Anne Tailleux, Gérard Torpier, et al.
Biochemical and Biophysical Research Communications|July 13, 2007
IP receptor-dependent activation of PPARgamma by stable prostacyclin analoguesEmilia Falcetti, David M Flavell, Bart Staels, et al.
Pageof 68